Clinical and soft-tissue computed tomographic predictors of dysthyroid optic neuropathy: Refinement of the constellation of findings at presentation

Archives of Ophthalmology

Volumn 129, Issue 10, 2011, Pages 1332-1336

  Weis, Ezekiel ^a   Heran, Manraj K S ^b   Jhamb, Ashu ^c   Chan, Andy K ^b   Chiu, Jack P ^b   Hurley, Michael C ^b   Rootman, Jack ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DYSTHYROID OPTIC NEUROPATHY; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; INTRAOCULAR PRESSURE; LAGOPHTHALMOS; MAJOR CLINICAL STUDY; MALE; MUSCLE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STRABISMUS; VISION; VISUAL ACUITY; VISUAL FIELD;

AREA UNDER CURVE; FALSE POSITIVE REACTIONS; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; MALE; MIDDLE AGED; OCULOMOTOR MUSCLES; OPTIC NERVE DISEASES; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; VISUAL ACUITY;

EID: 80053899774     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.276     Document Type: Article

References (26)

1. Wiersinga WM, Bartalena L. Epidemiology and prevention of Graves' ophthalmopathy. Thyroid. 2002;12(10):855-860. (Pubitemid 35332989)
2. Feldon SE, Muramatsu S, Weiner JM. Clinical classification of Graves' ophthalmopathy: identification of risk factors for optic neuropathy. Arch Ophthalmol. 1984;102(10):1469-1472. (Pubitemid 14048633)
3. Dosso A, Safran AB, Sunaric G, Burger A. Anterior ischemic optic neuropathy in Graves' disease. J Neuroophthalmol. 1994;14(3):170-174. (Pubitemid 24310643)
4. Koorneef L, Schmidt ED. The orbit: structure, autoantigens, and pathology. In: Wall J, How J, eds. Graves' Ophthalmolopathy. Vol 26. Oxford, England: Blackwell Scientific Publications; 1990:1-21.
5. Wiersinga WM, Kahaly GJ, eds. Graves Orbitopathy: A Multidisciplinary Approach. Basel, Switzerland: Karger; 2007.
6. McKeag D, Lane C, Lazarus JH, et al European Group on Graves' Orbitopathy (EUGOGO). Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey. Br J Ophthalmol. 2007;91(4):455-458. (Pubitemid 46623676)
7. Neigel JM, Rootman J, Belkin RI, et al. Dysthyroid optic neuropathy: the crowded orbital apex syndrome. Ophthalmology. 1988;95(11):1515-1521.
8. Hallin ES, Feldon SE. Graves' ophthalmopathy, II: correlation of clinical signs with measures derived from computed tomography. Br J Ophthalmol. 1988;72(9):678-682.
9. Trokel SL, Hilal SK. Submillimeter resolution CT scanning of orbital diseases. Ophthalmology. 1980;87(5):412-417. (Pubitemid 10102646)
10. Kennerdell JS, Rosenbaum AE, El-Hoshy MH. Apical optic nerve compression of dysthyroid optic neuropathy on computed tomography. Arch Ophthalmol. 1981;99(5):807-809. (Pubitemid 11120547)
11. Giaconi JA, Kazim M, Rho T, Pfaff C. CT scan evidence of dysthyroid optic neuropathy. Ophthal Plast Reconstr Surg. 2002;18(3):177-182. (Pubitemid 34547552)
12. Murakami Y, Kanamoto T, Tuboi T, Maeda T, Inoue Y. Evaluation of extraocular muscle enlargement in dysthyroid ophthalmopathy. Jpn J Ophthalmol. 2001;45(6):622-627. (Pubitemid 34081777)
13. Birchall D, Goodall KL, Noble JL, Jackson A. Graves ophthalmopathy: intracranial fat prolapse on CT images as an indicator of optic nerve compression. Radiology. 1996;200(1):123-127. (Pubitemid 26197349)
14. Nugent RA, Belkin RI, Neigel JM, et al. Graves orbitopathy: correlation of CT and clinical findings. Radiology. 1990;177(3):675-682.
15. Feldon SE, Lee CP, Muramatsu SK, Weiner JM. Quantitative computed tomography of Graves' ophthalmopathy: extraocular muscle and orbital fat in development of optic neuropathy. Arch Ophthalmol. 1985;103(2):213-215. (Pubitemid 15173958)
16. Barrett L, Glatt HJ, Burde RM, Gado MH. Optic nerve dysfunction in thyroid eye disease: CT. Radiology. 1988;167(2):503-507.
17. Dolman PJ, Rootman J. VISA classification for Graves orbitopathy. Ophthal Plast Reconstr Surg. 2006;22(5):319-324. (Pubitemid 44434337)
18. Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol. 1989;73(8):639-644. (Pubitemid 19202075)
19. Glynn RJ, Rosner B. Comparison of alternative regression models for paired binary data. Stat Med. 1994;13(10):1023-1036. (Pubitemid 24169929)
20. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29-36. (Pubitemid 12142173)
21. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837-845.
22. Rootman JR, ed. Diseases of the Orbit: A Multidisciplinary Approach. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003.
23. Weis E, Jhamb A, Chan AK, et al. Clinical-radiologic correlations in thyroid orbitopathy. Paper presented at: Swiss Symposium on Thyroid Eye Disease; December 7, 2007; Pontresina, Switzerland.
24. Naseem M, Donker DL, Paridaens D. Blepharoptosis as a sign of severe Graves'orbitopathy. Eye (Lond). 2009;23(8):1743-1744.
25. Sorisky A, Pardasani D, Gagnon A, Smith TJ. Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture. J Clin Endocrinol Metab. 1996;81(9):3428-3431. (Pubitemid 26296229)
26. Valyasevi RW, Erickson DZ, Harteneck DA, et al. Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J Clin Endocrinol Metab. 1999;84(7):2557-2562.